

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hyaluronic Acid,Ectoine,Fucoidan
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Lupin Ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Lupin Strengthens its Ophthalmology Business with Acquisition of VISUfarma
Details : The acquisition of VISUfarma, with its broad portfolio of innovative eye health products, including Xailin Ectoine, aligns with Lupin's strategy to expand its European business.
Product Name : Xailin Ectoine
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 29, 2025
Lead Product(s) : Hyaluronic Acid,Ectoine,Fucoidan
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Lupin Ltd
Deal Size : Undisclosed
Deal Type : Acquisition

Lead Product(s) : Fucoidan
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Nutrasource | University of South Carolina
Deal Size : Inapplicable
Deal Type : Inapplicable
Inflammatory and Immune Response After High Intensity Exercise
Details : Fucoidan is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 14, 2022
Lead Product(s) : Fucoidan
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Nutrasource | University of South Carolina
Deal Size : Inapplicable
Deal Type : Inapplicable

Details : Fucoidan is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Squamous Cell Carcinoma of Head and Neck.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
October 22, 2020

Lead Product(s) : Fucoidan
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Three Peace Co., Ltd., Japan
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Supplement Containing Fucoidan on Basal Body Temperature
Details : Fucoidan is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 21, 2011
Lead Product(s) : Fucoidan
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Three Peace Co., Ltd., Japan
Deal Size : Inapplicable
Deal Type : Inapplicable
